New CDER Center Could Boost Decentralized, Community-Based Trials

Experts say the new center set up by FDA drug officials to boost clinical trial innovation has the potential to increase diverse enrollment in trials, and they hope the new initiative will end up encouraging decentralized trials, including greater use of wearable apps, and community-based approaches to recruitment. A top drug center official recently told Inside Health Policy the new center will work to achieve faster adoption of decentralized clinical trials and other innovative trial formats that could increase...